What is triple-negative breast cancer?IRVIN, William J; CAREY, Lisa A.European journal of cancer (1990). 2008, Vol 44, Num 18, pp 2799-2805, issn 0959-8049, 7 p.Article

Adjuvant systemic therapy in young womenCARRIZOSA, Daniel R; CAREY, Lisa A.Breast disease. 2005, Vol 23, pp 67-71, issn 0888-6008, 5 p.Article

Clinical significance of micrometastatic disease in the era of sentinel nodeOLLILA, David W; CAREY, Lisa A; SARTOR, Carolyn I et al.Breast disease. 2000, Vol 12, pp 57-67, issn 0888-6008Article

Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast CancerFACKLER, Mary Jo; LOPEZ BUJANDA, Zoila; LYMAN, Jaclyn P et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 8, pp 2160-2170, issn 0008-5472, 11 p.Article

TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast CancerCAREY, Lisa A; RUGO, Hope S; WOLFF, Antonio C et al.Journal of clinical oncology. 2012, Vol 30, Num 21, pp 2615-2623, issn 0732-183X, 9 p.Article

Poly(ADP-Ribose) Polymerase Inhibition: Targeted Therapy for Triple-Negative Breast CancerANDERS, Carey K; WINER, Eric P; FORD, James M et al.Clinical cancer research (Print). 2010, Vol 16, Num 19, pp 4702-4710, issn 1078-0432, 9 p.Article

The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypesCAREY, Lisa A; DEES, E. Claire; SAWYER, Lynda et al.Clinical cancer research. 2007, Vol 13, Num 8, pp 2329-2334, issn 1078-0432, 6 p.Article

Radiation clastogenesis and cell cycle checkpoint function as functional markers of breast cancer riskKAUFMANN, William K; FILATOV, Leonid; CAREY, Lisa A et al.Carcinogenesis (New York. Print). 2006, Vol 27, Num 12, pp 2519-2527, issn 0143-3334, 9 p.Article

CYP2C8^*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxelHERTZ, Daniel L; MOTSINGER-REIF, Alison A; DROBISH, Amy et al.Breast cancer research and treatment. 2012, Vol 134, Num 1, pp 401-410, issn 0167-6806, 10 p.Article

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor―negative breast cancerHAIMAN, Christopher A; CHEN, Gary K; BAGLIETTO, Laura et al.Nature genetics. 2011, Vol 43, Num 12, pp 1210-1214, issn 1061-4036, 5 p.Article

Young Women with Locally Advanced Breast Cancer Who Achieve Breast Conservation after Neoadjuvant Chemotherapy Have a Low Local Recurrence RateSWEETING, Raeshell S; KLAUBER-DEMORE, Nancy; MEYERS, Michael O et al.The American surgeon. 2011, Vol 77, Num 7, pp 850-855, issn 0003-1348, 6 p.Conference Paper

When genomic and standard test results diverge: implications for breast cancer patients' preference for chemotherapyBREWER, Noel T; EDWARDS, Alrick S; O'NEILL, Suzanne C et al.Breast cancer research and treatment. 2009, Vol 117, Num 1, pp 25-29, issn 0167-6806, 5 p.Article

Research Issues Affecting Preoperative Systemic Therapy for Operable Breast CancerWOLFF, Antonio C; BERRY, Donald; SMITH, Mary Lou et al.Journal of clinical oncology. 2008, Vol 26, Num 5, pp 806-813, issn 0732-183X, 8 p.Article

Molecular classification and molecular forecasting of breast cancer : Ready for clinical application?BRENTON, James D; CAREY, Lisa A; AHMED ASHOUR AHMED et al.Journal of clinical oncology. 2005, Vol 23, Num 29, pp 7350-7360, issn 0732-183X, 11 p.Article

Effect of Cytotoxic Chemotherapy on Markers of Molecular Age in Patients With Breast CancerSANOFF, Hanna K; DEAL, Allison M; DROBISH, Amy et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 4, issn 0027-8874, 1.1-1.8Article

Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter StudyIRVIN, William J; WALKO, Christine M; RAAB, Rachel E et al.Journal of clinical oncology. 2011, Vol 29, Num 24, pp 3232-3239, issn 0732-183X, 8 p.Article

Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast CancerLIN, Nancy U; CAREY, Lisa A; XIAOCHUN LI et al.Journal of clinical oncology. 2008, Vol 26, Num 12, pp 1993-1999, issn 0732-183X, 7 p.Article

Clonal evolution of lymphoblastoid cell linesRYAN, Julie L; KAUFMANN, William K; RAAB-TRAUB, Nancy et al.Laboratory investigation. 2006, Vol 86, Num 11, pp 1193-1200, issn 0023-6837, 8 p.Article

Lymphatic mapping and sentinel lymphadenectomy prior to neoadjuvant chemotherapy in patients with large breast cancersOLLILA, David W; NEUMAN, Heather B; SARTOR, Carolyn et al.The American journal of surgery. 2005, Vol 190, Num 3, pp 371-375, issn 0002-9610, 5 p.Article

Current treatment paradigms for the management of patients with brain metastasesEWEND, Matthew G; ELBABAA, Samer; CAREY, Lisa A et al.Neurosurgery. 2005, Vol 57, Num 5, pp S4.66-S4.77, issn 0148-396X, SUPArticle

Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancerDEES, E. Claire; MCKINNON, Karen P; CAREY, Lisa A et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 9, pp 777-785, issn 0340-7004, 9 p.Article

Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian CancerIGLESIA, Michael D; VINCENT, Benjamin G; PARKER, Joel S et al.Clinical cancer research (Print). 2014, Vol 20, Num 14, pp 3818-3829, issn 1078-0432, 12 p.Article

Phase II Trial of Bicalutamide in Patients with Androgen Receptor―Positive, Estrogen Receptor―Negative Metastatic Breast CancerGUCALP, Ayca; TOLANEY, Sara; STEARNS, Vered et al.Clinical cancer research (Print). 2013, Vol 19, Num 19, pp 5505-5512, issn 1078-0432, 8 p.Article

Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancerLIPS, Esther H; MUKHTAR, Rita A; VAN'T VEER, Laura J et al.Breast cancer research and treatment. 2012, Vol 136, Num 1, pp 35-43, issn 0167-6806, 9 p.Article

Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancerVAN EMBURGH, Beth O; HU, Jennifer J; CAREY, Lisa A et al.Oncology reports. 2008, Vol 19, Num 5, pp 1311-1321, issn 1021-335X, 11 p.Article